> R&D > R&D Pipeline
RESEARCH
&DEVELOPMENT
R&D PIPELINE
Jinyang Pharm produces high-quality products through strict quality control.
- CATEGORY
- CLASSIFICATION
- PRODUCT
- PROOF OF CONCEPT
- FORMULATION STUDY
- STABILITY TEST
- CLINICAL STUDY / BE STUDY
- REGISTRATION
IMD |
SGLT2 Inhibitors |
JY302 |
※ We are currently conducting clinical trials for a new diabetes complex.
|
DPP-4 Inhibitors |
JY404 |
|
Cough & Cold remedies |
Sobnal A Tab. |
|
Generic |
H+ Pump Inhibitors |
Eszol Tab. |
|
Antilipidemic Agents |
Atovzet Tab.
Jintozet Tab.
|
|
Antihypertensives |
Amvaltan Tab. |
|
Antihypertensives |
Temistar Tab. |
|
SGLT2 Inhibitors |
JY301 |
|
DPP-4 Inhibitors |
JY401 |
|
DPP-4 Inhibitors |
JY402 |
|
DPP-4 Inhibitors |
JY403 |
|
P-CAB |
JY501 |
|
Written date: March 2022